Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Alimentary Pharmacology & Therapeutics|February 12, 2004
Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational studyJ R B Green, C H J Swan, J A Gibson, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 23, 2007
Routine postpartum ultrasonography in the prediction of puerperal uterine complicationsA H Shaamash, A G M Ahmed, M M Abdel Latef, et al.
Facts, Views & Vision in Obgyn|June 14, 2019
Uterine exteriorization versus intraperitoneal repair: effect on intraoperative nausea and vomiting during repeat cesarean delivery - A randomized clinical trialM S Abdellah, A M Abbas, M K Ali, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|November 1, 1992
Maternal mortality in AssiutS A Abdullah, E M Aboloyoun, H Abdel-Aleem, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1992
Short report: comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 monthsJ R Green, C H Swan, A Rowlinson, et al.
The Medical Journal of Malaysia|May 20, 2006
A prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with acute dysphagic strokeB B Hamidon, S A Abdullah, M F Zawawi, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1995
Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trialG D Bell, C M Bate, A T Axon, et al.
Gut|February 14, 1998
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study GroupJ J Misiewicz, A W Harris, K D Bardhan, et al.
Alimentary Pharmacology & Therapeutics|September 3, 1998
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study GroupA W Harris, J J Misiewicz, K D Bardhan, et al.
Alimentary Pharmacology & Therapeutics|January 9, 1999
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator groupJ R Green, J A Gibson, G D Kerr, et al.
Pageof 4